This series of events were filmed between November 2017 and January 2018 and are now available on-demand to watch at anytime until January 2019.
Please choose the event you wish to watch by clicking on the thumbnail below. Program content is the same for each of the three broadcasts.

  • Review the impact of underlying cardiovascular disease on antihyperglycemic selection
  • Examine new evidence impacting antihyperglycemic selection since the November 2016 Interim Update to the Diabetes Canada Clinical Practice Guidelines
  • Review the selection of antihyperglycemic medication for a patient without CVD who is not reaching glycemic targets with metformin monotherapy
  • Discuss the significance of CVD primary prevention results with antihyperglycemics

Please note that only the live episodes and not the on-demand archived videos are accredited by CCCEP.

CCCEP Statement of Completion (Adobe© PDF)
Dix vidéos archivées disponibles sur demande
This program was supported by AstraZeneca For more information: info@imedicus.ca